Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Plos One|May 1, 2020
Management of biliary stricture in patients with IgG4-related sclerosing cholangitisMasaki Miyazawa, Hajime Takatori, Kazunori Kawaguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 16, 2020
Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinomaTakeshi Terashima, Tatsuya Yamashita, Noboru Takata, et al.
Plos One|May 23, 2024
Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapyMiyabi Miura, Michiko Nishino, Kazunori Kawaguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 22, 2026
Potential Role of Liver Transplantation for Child-Pugh Class A Hepatocellular Carcinoma: Prognosis and Medical Expenditure in Japan-A Retrospective Single-Center StudyAkihiro Seki, Tomoyoshi Chiba, Shintaro Yagi, et al.
Life (Basel, Switzerland)|September 9, 2020
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with CirrhosisTsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, et al.
BMC Cancer|December 21, 2017
Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort studyTomoyuki Hayashi, Taro Yamashita, Takeshi Terashima, et al.
Gastro Hep Advances|October 27, 2025
Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti-Programmed Death-Ligand 1 and Anti-Vascular Endothelial Growth Factor-A AntibodiesGen Sugiyama, Kouki Nio, Hikari Okada, et al.
Viruses|February 27, 2026
Development of a Novel Human Hepatoma Cell Line Supporting the Replication of a Recombinant HBV Genome with a Reporter GeneShotaro Kawase, Tetsuro Shimakami, Kazuyuki Kuroki, et al.
Global Health & Medicine|January 1, 2025
Higher FIB-4 index at baseline predicts development of liver cancer in a community-based cohort with viral hepatitisMakiko Kimura, Tomoki Nishikawa, Tetsuro Shimakami, et al.
BJC Reports|January 14, 2025
Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinomaTakeshi Terashima, Kouki Nio, Naohiko Koshikawa, et al.
Pageof 8